Market Overview:
The global closed drug transfer systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of hospital-acquired infections (HAIs) and rising demand for safe and efficient drug delivery systems. Closed drug transfer systems are designed to prevent contact with hazardous drugs and minimize the risk of exposure to healthcare workers, patients, and visitors. These devices are available in different types such as closed vial access devices, closed syringe safety devices, closed bag/line access devices, and closed drug transfer system. The global market for hospital-based applications is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to the increasing number of hospitals worldwide coupled with rising demand for safe medication delivery solutions.
Product Definition:
Closed Drug Transfer Systems are defined as systems that allow for the secure and efficient transfer of medications from one location to another. The importance of Closed Drug Transfer Systems is that they help to ensure the safety and security of medications during transport.
Closed Vial Access Devices:
Closed vial access devices (CVAD) are used to transfer drugs in pharmaceutical manufacturing facilities. They are also used by the healthcare industry for research and development activities. The growth factor for CVAD market is increasing demand from developing countries such as China, India, Brazil, and Middle East countries due to rising R&D activities related to drug discovery & development.
Closed Syringe Safety Devices:
Closed syringe safety devices are used in closed drug transfer systems to prevent contamination of injectable drugs. These devices have the ability to reduce the risk of disease transmission as well as help avoid accidental consumption of contaminated drugs. The global market for closed syringe safety devices is expected to witness significant growth over the forecast period owing to increasing incidence rate of diseases such as hepatitis and AIDS, growing awareness about needle stick injuries, and rising number of surgical procedures globally.
Application Insights:
Based on the application, the global market has been segmented into hospital and clinic. The hospital segment dominated the overall market in terms of revenue in 2017. This is primarily due to factors such as an increase in surgical procedures, rise in number of hospitals & clinics and high prevalence of chronic diseases that require frequent drug administration for treatment. Moreover, a large number of pharmaceutical companies are focusing on manufacturing advanced products for healthcare professionals that will improve patient safety by reducing medication errors and improving workflow efficiency. These factors are expected to drive demand over the forecast period.
The Clinic segment is anticipated to exhibit significant growth over the forecast period owing to growing awareness about effective disease management practices coupled with increasing government initiatives related to diabetes care management across various regions worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of manufacturers and distributors, high adoption rate of automation across various industries, and increasing government initiatives for improving healthcare infrastructure. Moreover, rising prevalence of chronic diseases such as cancer is expected to drive demand for DTS in North America over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing population with changing lifestyle habits; increase in incidence rates of infectious diseases; rise in demand for quality medical devices that are compact & portable; need for rapid diagnosis & treatment options at remote locations during disasters or emergencies.; and an overall improvement in healthcare infrastructure especially due to government supportive measures.
Growth Factors:
- Increasing demand for Closed Drug Transfer Systems owing to their benefits over traditional systems
- Rising number of research and development activities in the field of drug delivery systems
- Technological advancements in the Closed Drug Transfer Systems market
- Growing focus on targeted drug delivery systems
- Rising prevalence of chronic diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Closed Drug Transfer Systems Market Research Report
By Type
Closed Vial Access Devices, Closed Syringe Safety Devices, Closed Bag/Line Access Devices, Closed Drug Transfer System
By Application
Hospital, Clinic
By Companies
BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical, Closed Drug Transfer System
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Closed Drug Transfer Systems Market Report Segments:
The global Closed Drug Transfer Systems market is segmented on the basis of:
Types
Closed Vial Access Devices, Closed Syringe Safety Devices, Closed Bag/Line Access Devices, Closed Drug Transfer System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD Medical, Inc
- Equashield, LLC
- ICU Medical, Inc
- Teva Medical Ltd
- Corvida Medical
- Closed Drug Transfer System
Highlights of The Closed Drug Transfer Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Closed Vial Access Devices
- Closed Syringe Safety Devices
- Closed Bag/Line Access Devices
- Closed Drug Transfer System
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Closed Drug Transfer Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Closed Drug Transfer Systems (CDTS) are a type of drug distribution system that is designed to prevent the illegal sale and use of drugs. CDTS systems are typically installed in pharmacies, hospitals, or other medical facilities. They use a secure computer network to track the movement of drugs and patients.
Some of the major players in the closed drug transfer systems market are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical, Closed Drug Transfer System.
The closed drug transfer systems market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Closed Drug Transfer Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Closed Drug Transfer Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Closed Drug Transfer Systems Market - Supply Chain
4.5. Global Closed Drug Transfer Systems Market Forecast
4.5.1. Closed Drug Transfer Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Closed Drug Transfer Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Closed Drug Transfer Systems Market Absolute $ Opportunity
5. Global Closed Drug Transfer Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Closed Drug Transfer Systems Market Size and Volume Forecast by Type
5.3.1. Closed Vial Access Devices
5.3.2. Closed Syringe Safety Devices
5.3.3. Closed Bag/Line Access Devices
5.3.4. Closed Drug Transfer System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Closed Drug Transfer Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Closed Drug Transfer Systems Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Closed Drug Transfer Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Closed Drug Transfer Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Closed Drug Transfer Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Closed Drug Transfer Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Closed Drug Transfer Systems Demand Share Forecast, 2019-2026
9. North America Closed Drug Transfer Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Closed Drug Transfer Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Closed Drug Transfer Systems Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Closed Drug Transfer Systems Market Size and Volume Forecast by Type
9.7.1. Closed Vial Access Devices
9.7.2. Closed Syringe Safety Devices
9.7.3. Closed Bag/Line Access Devices
9.7.4. Closed Drug Transfer System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Closed Drug Transfer Systems Demand Share Forecast, 2019-2026
10. Latin America Closed Drug Transfer Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Closed Drug Transfer Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Closed Drug Transfer Systems Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Closed Drug Transfer Systems Market Size and Volume Forecast by Type
10.7.1. Closed Vial Access Devices
10.7.2. Closed Syringe Safety Devices
10.7.3. Closed Bag/Line Access Devices
10.7.4. Closed Drug Transfer System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Closed Drug Transfer Systems Demand Share Forecast, 2019-2026
11. Europe Closed Drug Transfer Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Closed Drug Transfer Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Closed Drug Transfer Systems Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Closed Drug Transfer Systems Market Size and Volume Forecast by Type
11.7.1. Closed Vial Access Devices
11.7.2. Closed Syringe Safety Devices
11.7.3. Closed Bag/Line Access Devices
11.7.4. Closed Drug Transfer System
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Closed Drug Transfer Systems Demand Share, 2019-2026
12. Asia Pacific Closed Drug Transfer Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Closed Drug Transfer Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Closed Drug Transfer Systems Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Closed Drug Transfer Systems Market Size and Volume Forecast by Type
12.7.1. Closed Vial Access Devices
12.7.2. Closed Syringe Safety Devices
12.7.3. Closed Bag/Line Access Devices
12.7.4. Closed Drug Transfer System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Closed Drug Transfer Systems Demand Share, 2019-2026
13. Middle East & Africa Closed Drug Transfer Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Closed Drug Transfer Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Closed Drug Transfer Systems Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Closed Drug Transfer Systems Market Size and Volume Forecast by Type
13.7.1. Closed Vial Access Devices
13.7.2. Closed Syringe Safety Devices
13.7.3. Closed Bag/Line Access Devices
13.7.4. Closed Drug Transfer System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Closed Drug Transfer Systems Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Closed Drug Transfer Systems Market: Market Share Analysis
14.2. Closed Drug Transfer Systems Distributors and Customers
14.3. Closed Drug Transfer Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD Medical, Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Equashield, LLC
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ICU Medical, Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teva Medical Ltd
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Corvida Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Closed Drug Transfer System
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook